hair growth, stop hair loss



References: Hair growth and hair loss










  • Effect of Dermacentor albipictus (Acari:Ixodidae) on blood composition, weight gain and hair coat of moose, Alces alces.
  • Tick (Dermacentor albipictus)-induced winter hair-loss in captive moose (Alces alces).
  • Psychosomatic concepts in dermatology. A dermatologist-psychoanalyst's viewpoint.
  • Pathological changes developing in the rat during a 3-week course of high dosage cyclosporin A and their reversal following drug withdrawal.
  • Factors affecting the development of skin cancer after scalp irradiation.
  • Dexamethasone-cyclophosphamide pulse therapy in bullous autoimmune dermatoses
  • The effects of topical diazoxide on hair follicular growth and physiology of the stumptailed macaque.
  • Noonan syndrome: differential diagnosis with Turner's syndrome
  • Tissue-specific and differentiation-appropriate expression of the human involucrin gene in transgenic mice: an abnormal epidermal phenotype.
  • The risk of coronary heart disease in men with androgenetic alopecia.
  • Psychological problems associated with diagnosis and treatment of lymphomas. II: Prospective study.
  • The Brocq pseudopelade--a disease picture or disease entity
  • Nurse's cap alopecia.
  • Cell-mediated autoimmune diseases of the skin: some hypotheses.
  • Topical or systemic 16, 16 dm prostaglandin E2 or WR-2721 (WR-1065) protects mice from alopecia after fractionated irradiation.
  • Acute toxicity of adjuvant doxorubicin and cyclophosphamide for early breast cancer -- a retrospective review of Chinese patients and comparison with an historic Western series.
  • Untoward effects of low dose methotrexate therapy in rheumatoid arthritis
  • Protection against doxorubicin-induced alopecia in rats by liposome-entrapped monoclonal antibodies.
  • Clinical investigation of doxorubicin, daunomycin, and 6-thioguanine in normal cats.
  • Overexpression of Hoxc13 in differentiating keratinocytes results in downregulation of a novel hair keratin gene cluster and alopecia.
  • Pachyonychia congenita-like disorder in cotton-top tamarins (Saguinus oedipus oedipus).
  • Effects of ozonized autohaemotherapy on human hair cycle.
  • Disappointing results with dinitrochlorobenzene in alopecia areata
  • Baldness and ischemic heart disease in a national sample of men.
  • Congenital anemia, dyskeratosis, and progressive alopecia in Polled Hereford calves.
  • Subcutaneous blood flow in early male pattern baldness.
  • Methotrexate revisited: effects of long-term treatment in psoriasis.
  • Penetration and side effects of local estrogen application in alopecia androgenetica
  • A controlled study of the effects of RU58841, a non-steroidal antiandrogen, on human hair production by balding scalp grafts maintained on testosterone-conditioned nude mice.
  • Evidence for a single gene effect causing polycystic ovaries and male pattern baldness.
  • Alopecia areata: light and electron microscopic pathology of the regrowing white hair.
  • Our experience with endoscopic brow lifts.
  • Non-organ-specific autoimmunity in alopecia.
  • Kerion Celsi: a clinical epidemiological study.
  • A phase II study of epirubicin in acute leukemia: a cooperative group study.
  • Management of clinical side effects of DMPA.
  • Adriamycin, cisplatin, and etoposide combination chemotherapy for small cell lung cancer
  • Treatment of male baldness exclusively with mini-grafts
  • Valproic acid in childhood epilepsy: anticonvulsive efficacy in relation to its plasma levels.
  • Chronic discoid lupus erythematosus: an immunopathological and electron microscopic study.
  • Evaluation of serum estradiol concentrations in alopecic ferrets with adrenal gland tumors.
  • Relative influence of ethanol and propylene glycol cosolvents on deposition of minoxidil into the skin.
  • Phase II study with etoposide in previously untreated advanced breast cancer.
  • Alopecia areata and auto-immunity.
  • A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group
  • Cell degeneration in alopecia areata. An ultrastructural study.
  • Hairdex: a tool for evaluation of disease-specific quality of life in patients with hair diseases
  • Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) chemotherapy for advanced urothelial cancers
  • Scalp lifting. An 8-year experience with over 1,230 cases.
  • Cyclosporine and experimental skin allografts. II. Indefinite survival and development of specific immunologic unresponsiveness.
  • Intervening with alopecia: exploring an entrepreneurial role for oncology nurses.
  • Research in practice: an 'experiment' in researcher-practitioner collaboration.
  • Osteopontin gene is expressed in the dermal papilla of pelage follicles in a hair-cycle-dependent manner.
  • Scalp extension.
  • The function of the autonomic nervous system in women with androgenetic alopecia
  • Selenium poisoning in fattening swine
  • A case of Mongolism in DZ female twins studied at 10 and then at 43 years of age.
  • Postmenopausal frontal fibrosing alopecia: 20 cases
  • Single-agent paclitaxel as first-line treatment of metastatic breast cancer: the British experience.
  • VP-16 and cisplatin as first-line therapy for small-cell lung cancer.
  • Use of parieto-occipital flaps in the surgical treatment of baldness.
  • Scalp expansion flaps.
  • Type IV immunity in alopecia areata in a comparison of 2 test methods
  • Cryosectioning of hair follicles. An improved method using liquid nitrogen conduction freezing.
  • Vesicle formation and follicular root sheath separation in mice homozygous for deleterious alleles at the balding (bal) locus.
  • Skin lesions treated with azathioprine and prednisone. Comparison of nontransplant patients and renal transplant recipients.
  • Reversal of Hair Loss following Vertical Gastroplasty when Treated with Zinc Sulphate.
  • Histogenesis of mucin in follicular mucinosis. An electron microscopic study.
  • Treatment of severe alopecia areata with topical applications of cyclosporin A
  • Modulation of murine hair follicle function by alterations in ornithine decarboxylase activity.
  • Behaviour-associated alopecia areata in mice.
  • Idarubicin oral: new formulation. No proven benefit over 60.
  • Dermatologic indications for anti-androgenic treatment
  • Skin changes after forty.
  • Interleukin 1 protects hair follicles from cytarabine (ARA-C)-induced toxicity in vivo and in vitro.
  • Improvement in radiotherapy for a murine sarcoma by indomethacin plus WR-2721.
  • Treating cicatricial baldness with scalp expanding and hair autografting
  • Total thyroxine (T4) and free thyroxine (FT4) in hypothyroidism and nonthyroid diseases of dogs
  • Evaluation of thyroid function in dogs suffering from recurrent flank alopecia.
  • Alopecia areata, endocrine function, and autoantibodies in patients 16 years of age or younger.
  • Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system.
  • Locus of dominant hairless gene (Ht) causing abnormal hair and keratinization maps to rat chromosome 10.
  • Large doses of glucocorticoid in the treatment of alopecia areata.
  • Plasma testosterone glucosiduronate: a reliable indicator of female hyperandrogenism (idiopathic hirsutism and androgenic alopecia).
  • The punch scalp graft.
  • Advancement in scalp grafts.
  • Measurement of human hair growth by optical microscopy and image analysis.
  • A new scalp flap for baldness.
  • The genetics of human hair growth.
  • Morphological analysis of hair in the hr-2 mutant deer mouse (Peromyscus maniculatus).
  • Morphological analysis of hair follicles in alopecia areata.
  • A technique for hair-grafting in between existing follicles in patients with early pattern baldness.
  • Quantification of scalp hair--a computer-aided methodology.
  • I think I'm losing my hair.
  • Update on laser-assisted hair transplantation.
  • Predicting hair growth for hair transplantations.
  • Hydroxyurea--is it a harmless drug in Vaquez disease?
  • Effect of skin-graft harvesting on hair growth; implications for the study of alopecia.
  • Medical treatment of baldness.
  • Androgenetic alopecia in heterozygous carriers of a mutation in the human hairless gene.
  • A morphometric and histologic study of the scalp in psoriasis. Paradoxical sebaceous gland atrophy and decreased hair shaft diameters without alopecia.
  • Trichotillomania: a histopathologic study in sixty-six patients.
  • Familial alopecia areata. HLA antigens and autoantibody formation in an American family.
  • The physician as Sherlock Holmes. Accident, murder by poisoning or suicide?
  • Relations between sex hormone level and characters of hair and skin in healthy young men.
  • Immunotherapy trial for horses in British Columbia with Culicoides (Diptera:Ceratopogonidae) hypersensitivity.
  • Targeting expression of the human vitamin D receptor to the keratinocytes of vitamin D receptor null mice prevents alopecia.
  • A phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with head and neck cancer
  • Disturbed release of growth hormone in mature dogs: a comparison with congenital growth hormone deficiency.
  • A case-control study of baldness in relation to myocardial infarction in men.
  • Pharmacological action of 101-B hair regeneration extract on skin and hair in experimental animals
  • Oral cyclosporin A restores hair growth in the DEBR rat model for alopecia areata.
  • Effect of finasteride on human testicular steroidogenesis.
  • Detection of antibodies to human melanoma cells in vitiligo and alopecia areata by Western blot analysis.
  • X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein.
  • Efficacy of hyposensitization in feline allergic diseases based upon results of in vitro testing for allergen-specific immunoglobulin E.
  • Corneal lesions in ichthyosis
  • Hormonotherapy in acute, idiopathic hirsutism, and seborrheic alopecia
  • Laser hair transplantation II.
  • Alopecia areata: immunohistochemistry and ultrastructure of infiltrate and identification of adhesion molecule receptors.
  • Side effects in immunosuppressive therapy
  • In vivo radioprotective activities of diethyldithiocarbamate (DDC).
  • Topical FK506: a potent immunotherapy for alopecia areata? Studies using the Dundee experimental bald rat model.
  • A rapid micrograft implantation technique.
  • Treatment with ImuVert/N-acetylcysteine protects rats from cyclophosphamide/cytarabine-induced alopecia.
  • Baldness: indications
  • Phase II study of (2''R)-4'-O-tetrahydropyranyldoxorubicin (THP) in patients with advanced gastrointestinal cancer--a report of the Tohoku THP Study Group
  • The value of serologic inflammatory parameters in the diagnosis of alopecia areata
  • Alopecia induced by inhalation exposure to phenyl glycidyl ether.
  • Interleukin-1beta-induced inhibition of hair growth in vitro is mediated by cyclic AMP.
  • Hair cycle and alopecia.
  • IL-1 synergizes with ARA-C in aborting the development of chloroleukemia while protecting from ARA-C-induced alopecia in the rat model.
  • Physiopathological role of bald-scalp cytosolic proteins.
  • Lymphocyte subpopulations in alopecia areata
  • Acute monoblastic leukemia in infancy and early childhood: successful treatment with an epipodophyllotoxin.
  • Immunostimulation therapy in patients with alopecia areata
  • Guanylate cyclase activity in male pattern baldness. Stimulating effect of 3-beta-androstanediol.
  • Hyperinsulinemia is common in family members of women with polycystic ovary syndrome.
  • Immediate postpartum insertion of the norplant contraceptive device.
  • The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia.
  • Skin and hair follicle integrity is crucially dependent on beta 1 integrin expression on keratinocytes.
  • Alopecia areata and interleukin-2 receptor.
  • Clinical evaluation of intra-arterial methotrexate, vinblastine, doxorubicin and cis-platinum for bladder cancer
  • Is 3 alpha, 17 beta-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
  • Laser surgery for vulvar intraepithelial neoplasia: principles and results.
  • Trichological examinations in women suffering from diabetes mellitus
  • Spontaneous zinc deficiency in marmosets, saguinus mystax.
  • Endocrinological disorders in association with alopecia areata-a 27 patients study
  • Transfer of alopecia areata in the human scalp graft/Prkdc(scid) (SCID) mouse system is characterized by a TH1 response.
  • Haemorheological parameters in alopecia areata.
  • Action of topical minoxidil in the bald stump-tailed macaque.
  • Vindesine as a single agent in the treatment of advanced malignant melanoma.
  • Normal sweat secretion rate in patients with alopecia areata.
  • Cutaneous manifestations of idiopathic hermochromatosis.Study of 100 cases.
  • Analysis of the relation between alopecia and resistance to 1,25-dihydroxyvitamin D.
  • Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.
  • Systemic toxicity after isolated limb perfusion with melphalan for melanoma.
  • RXR-alpha ablation in skin keratinocytes results in alopecia and epidermal alterations.
  • Analysis of cataract and keratotic damage induced by 4-diethylaminoethoxy-alpha-ethyl-benzhydrol (RGH-6201) in rats.
  • Alopecia of IFN-gamma knockout mouse as a model for disturbance of the hair cycle: a unique arrest of the hair cycle at the anagen phase accompanied by mitosis.
  • Stability studies on L-ascorbic acid dl-alpha-tocopherol phosphoric acid diester potassium salt (EPC-K)
  • Removal rates of subdermal levonorgestrel implants.
  • Atrichia with papular lesions resulting from mutations in the rhesus macaque (Macaca mulatta) hairless gene.
  • Contact thermometry of lesions in alopecia areata
  • The virulence of L. leucocephala for goats in northeastern Mexico
  • Serial scalp reductions: a biomechanical approach.
  • Adolescents' use of levonorgestrel implants for contraception.
  • The subcutaneous forehead lift with an anterior hairline incision.
  • Hepatic encephalopathy and light and electron micrographic changes of the baboon liver after portal diversion.
  • Biochemical changes and liver tissue pathology in weanling Wistar albino rats with protein-energy malnutrition (PEM).
  • Primary chemotherapy for locally advanced uterine cervical carcinoma.
  • Hair transplantation using local hypothermia.
  • Stressful life events and loss of hair among adult women, a case-control study.
  • Locks of love.
  • Plasma C19 steroid sulphate levels and indices of androgen bioavailability in female pattern androgenic alopecia.
  • Spontaneous autoimmune skin lesions of MRL/n mice: autoimmune disease-prone genetic background in relation to Fas-defect MRL/1pr mice.
  • Studies on the effect of bleomycin on hair growth dynamics in rats
  • The significance of lymphocytic differentiation antigens in the diagnosis and therapy of alopecia areata
  • Mitoxantrone in malignant lymphoma.
  • Thyroid antibodies in alopecia totalis.
  • A study of etretinate alopecia.
  • The prevalence of skin manifestations in thyrotoxicosis--a retrospective study.
  • Combined modalities in the management of advanced head and neck cancers.
  • Male-pattern alopecia and masculinity.
  • Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
  • The use of Adriamycin and mehtotrexate in carcinoma of the cervix. The development of a safe effective regimen.
  • Evidence that the effector mechanism of skin allograft rejection is antigen-specific.
  • Seasonal flank alopecia in boxers and Airedale terriers: 24 cases (1985-1992).
  • The occipito-parietal flap method in the treatment of male baldness.
  • Chemotherapy of metastasizing breast cancer. Adriamycin mono and combination therapy after LMFP pretreatment
  • Characterization of Bsk mice: I. The Bsk mutation does not involve a recombination of cornea-specific keratin 12 and skin-specific hair keratin genes.
  • Characterization of microbial presence at the surface of silicone mammary implants.
  • Potential mechanisms of minoxidil-induced hair growth in alopecia areata.
  • Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris.
  • Personal experiences with Minitrol
  • Cisplatin, peplomycin, mitomycin C, and vincristine combination chemotherapy of non-small cell carcinoma of the lung
  • A phase II study of mitoxantrone in advanced breast cancer.
  • The follicular automaton model: effect of stochasticity and of synchronization of hair cycles.
  • Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
  • Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling.
  • Nonuniform expression of a mouse mammary tumor virus-driven int-2/Fgf-3 transgene in pregnancy-responsive breast tumors.
  • Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene.
  • Expression of DeltaNLef1 in mouse epidermis results in differentiation of hair follicles into squamous epidermal cysts and formation of skin tumours.
  • Follicular unit extraction: minimally invasive surgery for hair transplantation.
  • Expression of extracellular matrix in hair follicle mesenchyme in alopecia areata.
  • Adjuvant chemotherapy with mitoxantrone, cyclophosphamide and 5-fluorouracil in breast neoplasms: therapeutic life
  • Evaluation of multidisciplinary treatment of bladder cancer, especially in chemoimmunotherapy (ADM and OK-432) as a consolidation therapy.
  • Hairpatches, a single gene mutation characterized by progressive renal disease and alopecia in the mouse. A potential model for a newly described heritable human disorder.
  • 'Cyclic alopecia' in Msx2 mutants: defects in hair cycling and hair shaft differentiation.
  • Changes in self-concept and body image during alopecia induced cancer chemotherapy.
  • Benign idiopathic versus mycosis fungoides-associated follicular mucinosis.
  • Utilization of No-Kor needles for slit-micrografting.
  • Tinea capitis in The Netherlands (Rotterdam area).
  • Evaluation of alopecia: a new algorithm.
  • Topical application of nitroxide protects radiation-induced alopecia in guinea pigs.
  • Advanced male non-seminomatous germ-cell tumours. Combination chemotherapy with cis-platinum, vinblastine and bleomycin.
  • Progression of tumours and non-neoplastic disorders as manifestations of a common biological phenomenon.
  • Permanent hair removal by normal-mode ruby laser.
  • Phase I clinical trial of a new anthracycline: 4'-o-tetrahydropyranyl adriamycin.
  • Damage to hair follicles by normal-mode ruby laser pulses.
  • Palliative treatment of brain metastases with gamma knife
  • Cytokines in alopecia areata: contrasting cytokine profiles in localized form and extensive form (alopecia universalis).
  • Pleiotropic effects of the nude mutation.
  • The effectiveness of occipital artery ligations as a priming procedure for extensive scalp-lifting.
  • Efficacy and acceptability of depo-medroxyprogesterone acetate injection. As a method of contraception in Saudi Arabia.
  • Phase I study with 4'-deoxydoxorubicin.
  • Study of the zinc content of hair and serum in selected skin diseases
  • Hepato- and thyreotoxicity of tifemoxone.
  • Dermatology and polyposis of the gastro-intestinal tract
  • How well do medical oncologists' perceptions reflect their patients' reported physical and psychosocial problems? Data from a survey of five oncologists.
  • Immunofluorescence studies on C1Q in mast cells.
  • Quantitative image analysis of hair follicles in alopecia areata.
  • Hairless cats in Great Britain.
  • Adriamycin in the treatment of childhood solid tumors. A Southwest Oncology Group study.
  • Mucocutaneous complications of intraarterial 5-bromodeoxyuridine and radiation.
  • Effectiveness and toxicity of high-dosage Ara-C. Clinical observations in 10 cases and review of the literature
  • Dermatopathological studies on skin lesions of MRL mice.
  • Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex.
  • Cloning, genomic organization, alternative transcripts and mutational analysis of the gene responsible for autosomal recessive universal congenital alopecia.
  • Thallium poisoning: an outbreak in Florida, 1988.
  • Prevalence of polycystic ovaries in women with androgenic alopecia.
  • Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion.
  • The influence of several ovulation inhibiting hormone preparations on scalp hair growth
  • Melanocytic population of buccal mucosa of patients with lichen planus
  • Weekly administration of paclitaxel and pirarubicine for recurrent breast cancer
  • Do dietary levels of pantothenic acid regulate its intestinal uptake in mice?
  • Value of laboratory parameters in androgenization in the female with special reference to the "free androgen index"
  • Alopecia areata. A pathological study of nonresponder patients.
  • Hair root studies in patients suffering from primary and secondary syphilis.
  • Response of grafts from patients with alopecia areata transplanted onto nude mice, to administration of interferon-gamma.
  • Immunological studies in patients with alopecia areata.
  • Medical treatment of male pattern alopecia (androgenic alopecia).
  • Fibrosing alopecia in a pattern distribution: patterned lichen planopilaris or androgenetic alopecia with a lichenoid tissue reaction pattern?
  • Tissue expansion in the pediatric patient.
  • Alopecia areata in aging C3H/HeJ mice.
  • Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris.
  • Impaired responses of peripheral blood mononuclear cells to T-cell stimulants in alopecia areata patients with a poor response to topical immunotherapy.
  • Expression of tenascin in perifollicular connective tissue: comparison of normal scalp and alopecia areata.
  • Phase I clinical and pharmacokinetic study of taxol.
  • A variable monilethrix phenotype associated with a novel mutation, Glu402Lys, in the helix termination motif of the type II hair keratin hHb1.
  • Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of care.
  • Incontinentia pigmenti
  • A phase II study of pirarubicin in malignant pleural mesothelioma.
  • Hormones and hair patterning in men: a role for insulin-like growth factor 1?
  • The distress associated with cranial irradiation: a comparison of patient and nurse perceptions.
  • Status of adriamycin in cancer therapy
  • Patient-perceived importance of negative effects of androgenetic alopecia in women.
  • How women receiving adjuvant chemotherapy for breast cancer cope with their treatment: a risk management perspective.
  • Feasibility of external beam radiation for prevention of restenosis following balloon angioplasty.
  • Skin abnormalities generated by temporally controlled RXRalpha mutations in mouse epidermis.
  • Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
  • Male pattern baldness is not associated with established cardiovascular risk factors in the general population.
  • Study on parents phenotypes in women with polycystic ovary syndrome
  • Forced convection around the human head.
  • research_abst
  • Leptin modulates the effects of acyl CoA:diacylglycerol acyltransferase deficiency on murine fur and sebaceous glands.
  • MMAF for advanced gastric cancer.
  • Immunological study of alopecia areata
  • Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(scid) mice.
  • The rat shorn mutation (shn) maps between D7Got143 and D7Rat94.
  • Oral contraceptives: current status of therapy.
  • Androgen-inducible TGF-beta1 from balding dermal papilla cells inhibits epithelial cell growth: a clue to understand paradoxical effects of androgen on human hair growth.
  • A missense mutation in CDH3, encoding P-cadherin, causes hypotrichosis with juvenile macular dystrophy.
  • Occipital alopecia following cardiopulmonary bypass.
  • Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing.
  • research_abst
  • Managing cancer: the role of holiday taking.
  • Prevention by hypothermic cap of antiblastic induced-alopecia.
  • CSF 5-HIAA as a predictor of treatment response in trichotillomania.
  • Prevalence and indicators of HIV and AIDS among adults admitted to medical and surgical wards in Blantyre, Malawi.
  • Forum: dermopigmentation or medical tattooing. Dermopigmentation with an esthetic aim. Apropos of 420 cases
  • Abnormal expression of Ki-67 antigen in hair follicle of alopecia areata.
  • Health-related challenges in United States Peace Corps Volunteers serving for two years in Madagascar.
  • Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.
  • DPCP for the treatment of alopecia areata.
  • Topical estrogen accelerates hair regrowth in mice after chemotherapy-induced alopecia by favoring the dystrophic catagen response pathway to damage.
  • Alopecia universalis treated with oral cyclosporine A and prednisolone: immunologic studies.
  • Dinitrochlorobenzene therapy for alopecia areata.
  • Rapid Fire Hair Implanter Carousel. A new surgical instrument for the automation of hair transplantation.
  • The psychological effects of androgenetic alopecia in men.
  • Trichotillomania: a clinical study of 36 patients.
  • The effect of dietary change on in vitro erythrocyte haemolysis, skin lesions and alopecia in common marmosets (Callithrix jacchus).
  • Phase II study of teniposide in patients with AIDS-related Kaposi's sarcoma.
  • Soft tissue expansion in the treatment of scar alopecia in preschool children.
  • Cutaneous manifestations in trisomy 21
  • Hormones and hair growth in man
  • Anomalies in transgenic mice carrying the human interleukin-2 gene.
  • Combination chemotherapy of ifosfamide, cisplatin and vindesine for non-small cell lung cancer
  • Combination radiotherapy and chemotherapy for small cell carcinoma of the lung.
  • Anxiety structure and catecholamine parameters in patients with rosacea, alopecia areata and lichen ruber planus
  • Ultrastructural observations on the hair bulb melanocytes and melanosomes in acute alopecia areata.
  • Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer.
  • Planning of a local flap of expanded scalp for repair of alopecia cicatrisata
  • Magnesium deficiency affects the pentylenetetrazol-induced convulsions in magnesium-deprived rats.
  • Control beliefs and patient compliance: an empirical study exemplified by adolescents with diabetes mellitus, bronchial asthma and alopecia areata
  • A phase I study of menogaril in patients with advanced cancer.
  • Physiopathological approach to seborrhea of the scalp
  • Treatment of alopecia areata with dinitrochlorobenzene.
  • Mitoxantrone, 5-fluorouracil and cyclophosphamide in advanced breast cancer.
  • Advantages of the paramedian scalp reduction.
  • Subcutaneous or topical administration of 16,16 dimethyl prostaglandin E2 protects from radiation-induced alopecia in mice.
  • Phase II study of idarubicin given orally in the treatment of anthracycline-naive advanced breast cancer patients.
  • Evaluation of oral minoxidil in the treatment of alopecia areata.
  • Dermatologic diseases of the nail unit other than psoriasis and lichen planus.
  • Immunological profiles in alopecia areata.
  • Hair loss. Common congenital and acquired causes.
  • Cell-mediated immunity in alopecia areata.
  • Hematopoiesis and aging III: Anemia and a blunted erythropoietic response to hemorrhage in aged mice.
  • Cytokeratin expression in alopecia areata hair follicles.
  • Estrus, ovulation, and serum progesterone, estradiol, and LH concentrations in mares after an increased photoperiod during winter.
  • A nationwide outbreak of alopecia associated with the use of a hair-relaxing formulation.
  • Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata.
  • DNCB therapy of alopecia areata
  • A three-year follow-up study of psoriasis patients treated with low dosages of etretinate orally and corticosteroids topically.
  • Treatment of recurrent small cell lung carcinoma with vindesine and cisplatin.
  • Treatment of androgenic alopecia with topical minoxidil
  • Combination chemotherapy for metastatic breast cancer with fluorouracil, adriamycin, cyclophosphamide, and methotrexate.
  • Genetic control of alopecia in sheep
  • Phase I toxicologic study of Lonidamine in cancer patients.
  • Scanning electron microscopy of the cochlea in rats with Streptococcus pneumoniae otitis media.
  • A multicentre phase II trial of vindesine in malignant melanoma.
  • Treatment of alopecia areata with DNCB--an immunostimulation?
  • Short vs long scalp flaps in the treatment of male pattern baldness.
  • Apoptosis of hair follicle cells during doxorubicin-induced alopecia in rats.
  • Telogen effluvium following application of selenium disulfide in the guinea pig
  • Tumor necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata.
  • Novel cycle changes in scalp hair are caused by etretinate therapy.
  • Treatment of severe alopecia areata with squaric acid dibutylester in pediatric patients.
  • The selection of appropriate health education topics for publication in the press.
  • Chemofiltration for locally advanced cancer
  • Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis.
  • Ophthalmologic oncology: alopecia of the eyelashes.
  • Transverse scalp sections: a proposed method for laboratory processing.
  • Lymphocyte-mediated alopecia in C57BL/6 mice following successful immunotherapy for melanoma.
  • Regression of pathologic changes induced by the long-term administration of contraceptive steroids to rodents.
  • Cytokines and growth factors influence hair growth in vitro. Possible implications for the pathogenesis and treatment of alopecia areata.
  • Activation of cytoprotective prostaglandin synthase-1 by minoxidil as a possible explanation for its hair growth-stimulating effect.
  • Sideburn reconstruction with an expanded supraauricular trapezoidal flap.
  • The aesthetics of follicular transplantation.
  • Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp.
  • Small mammal populations and community under conditions of extremely high thallium contamination in the environment.
  • Dermatological indicators of coronary risk: a case-control study.
  • Reduction of arthritis and pneumonitis in motheaten mice by soluble tumor necrosis factor receptor.
  • Juvenile autoimmune polyendocrinopathy.
  • Analysis of genetic polymorphisms of steroid 5alpha-reductase type 1 and 2 genes in Korean men with androgenetic alopecia.
  • Sexual concerns of adolescents with cancer.
  • Hypotrichosis in Miniature Poodle siblings.
  • Teratogenic effects in a population based on a model of the bone system of the human embryo
  • Characterization of a potential animal model of an idiosyncratic drug reaction: nevirapine-induced skin rash in the rat.
  • Liposomal daunorubicin: new preparation. Kaposi's sarcoma: occasional remission.
  • Natural progression of male pattern baldness in young men.
  • Syndrome of cystic eyelids, palmo-plantar keratosis, hypodontia and hypotrichosis as a possible autosomal recessive trait.
  • Updating reduction and flap procedures for baldness.
  • Peripheral blood lymphocyte populations and phagocytic functions in patients with active alopecia areata.
  • Occurrence and severity of alopecia in patients on combination chemotherapy.
  • A scalp garment for prestretching prior to alopecia-reducing procedures.
  • Hostile personality characteristics, dysthymic states and neurotic symptoms in urticaria, psoriasis and alopecia.
  • Scalp cooling in the prevention of alopecia in patients receiving depilating chemotherapy.
  • Scalp hypothermia in the prevention of chemotherapy-induced alopecia.
  • Tonsure reduction. Principles and innovation: scalp lift
  • Genetic linkage studies in alopecia areata.
  • Embryotoxicity study of propenoic acid, 3-(4-methoxyphenyl)-3-methylbutylester in the Wistar rat.
  • Capillary electrophoretic profiling of rat hair: a tool for alopecia areata diagnosis.
  • Association of benign prostatic hyperplasia with male pattern baldness.
  • Evaluation of the LSA2L2 protocol for treatment of childhood non-Hodgkin's lymphoma. A report from the Polish Children's Leukemia/Lymphoma Study Group.
  • Chlorambucil, vinblastine, procarbazine, and prednisone. An effective but less toxic regimen than MOPP for advanced-stage Hodgkin's disease.
  • Characterization of psoriasiform and alopecic skin lesions in HLA-B27 transgenic rats.
  • Protection against chemotherapy-induced alopecia by cyclosporin A in the newborn rat animal model.
  • Lifetime prevalence of psychiatric disorders in patients with alopecia areata.
  • Sterile eosinophilic pustulosis
  • Computer-aided quantification of scalp hair.
  • Combination chemotherapy ("CHOP-Bleo") in advanced (non-Hodgkin) malignant lymphoma.
  • Modification of radiation-induced carcinogenesis in mice by misonidazole and WR-2721.
  • Pathomorphology of radiation sickness in sheep following whole body roentgen irradiation
  • Ifosfamide, mitomycin and radiotherapy in non-small-cell lung cancer.
  • Facial hair barbering in rats.
  • Follicular mucinosis. A reaction pattern in follicular epithelium.
  • Epidermal dexamethasone receptors in dogs with confirmed hyperadrenocorticalism, hypothyroidism or undiagnosed hormonal alopecia.
  • Prevention of chemotherapy-induced alopecia by cyclin-dependant kinase inhibitors
  • Telogen effluvium due to recombinant interferon alpha-2b.
  • "Stretch-back" in scalp reductions for male pattern baldness.
  • New devices for scalp reduction. Intraoperative and prolonged scalp extension.
  • High-dose teniposide for refractory malignancies: a phase I study.
  • Factors affecting hair regrowth after bone marrow transplantation.
  • Phase I study of high dose 5-fluorouracil and high dose Leucovorin with low dose phosphonacetyl-L-aspartic acid in patients with advanced malignancies.
  • Notch/RBP-J signaling regulates epidermis/hair fate determination of hair follicular stem cells.
  • Role of cytomegalovirus replication in alopecia areata pathogenesis.
  • Cancer chemotherapy via ambulatory infusion pump.
  • The Burow's triangle scalp reduction. A new and improved technique for paramedian scalp reduction.
  • Protection from chemotherapy-induced alopecia in a rat model.
  • Phospholipase Cdelta1 is required for skin stem cell lineage commitment.
  • Hair loss, insulin resistance, and heredity in middle-aged women. A population-based study.
  • Factors influencing the response of normal tissue to radiation
  • Side effects and late results of the combined radio- and chemotherapy of the brain in children with acute lymphoblastic leukemia
  • Is androgenic alopecia a result of endocrine effects on the vasculature?
  • The forehead lift. A review.
  • Treatment of refractory rheumatoid arthritis--the thalidomide experience.
  • A review of 324 rhytidectomies, emphasizing complications and patient dissatisfaction.
  • Hair transplantation, scalp reduction, and flap rotation in black men.
  • Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice.
  • Intra-arterial infusion chemotherapy with epirubicin for advanced breast cancer
  • Skeletal abnormalities in Satoyoshi's syndrome: a radiographic study of eight cases.
  • BAC-mediated gene-dosage analysis reveals a role for Zipro1 (Ru49/Zfp38) in progenitor cell proliferation in cerebellum and skin.
  • Two-color flow cytometry analysis in alopecia areata.
  • Effects of galeotomies on scalp flaps.
  • Tinea capitis infection in school children of Nepal.
  • Tufted folliculitis of the scalp: a distinctive clinicohistological variant of folliculitis decalvans.
  • Wigs as medical aids. Selection, care and cost regulation
  • Trichotillomania and self-esteem: a survey of 62 female hair pullers.
  • Loss of contact sensitization evaluated by laser Doppler blood flowmetry and transepidermal water loss measurement.
  • Clinical manifestations of secondary syphilis.
  • Intra-arterial infusion chemotherapy with anticancer agents for advanced breast cancer--effect and toxicity of mitomycin C and adriamycin
  • In vivo activity of sertaconazole in experimental dermatophytosis in guinea pigs.
  • Treatment of moderately severe virilism of women with Diane and Androcur 10
  • A community study of male androgenetic alopecia in Bishan, Singapore.
  • Examination of the significance of psychological factors in the etiology of alopecia areata. I. Examining Type A behavior
  • Alopecia syphilitica, a simulator of alopecia areata: histopathology and differential diagnosis.
  • Alopecia universalis as a single abnormality in an inbred Pakistani kindred.
  • Hair and skin disorders as signs of mitochondrial disease.
  • Murine graft-versus-host skin disease: a chronologic and quantitative analysis of two histologic patterns.
  • Growth inhibition of mouse skin tumor by serine protease inhibitor ONO-3403.
  • Induction of experimental SLE in naive mice by immunization with human polyclonal anti-DNA antibody carrying the 16/6 idiotype.
  • Patients' experiences of chemotherapy: side-effects associated with 5-fluorouracil + folinic acid in the treatment of colorectal cancer.
  • DNCB therapy for alopecia areata
  • Hormonal diagnosis in so-called androgenetic alopecia in the female
  • Tufted folliculitis. A specific bacterial disease?
  • Reduction of regrowing hair shaft size and pigmentation after ruby and diode laser treatment.
  • research_abst
  • Tumor induction by a single subcutaneous injection of N-methyl-N'-nitro-N-nitrosoguanidine and its derivatives in newborn mice.
  • The follicular degeneration syndrome in black patients. 'Hot comb alopecia' revisited and revised.
  • Beards, baldness, and sweat secretion.
  • The feasibility of targeted selective gene therapy of the hair follicle.
  • Studies on 'zinc deficiency syndrome' in black bengal goats (Capra hircus) fed with fodder (Andropogon gayanus) grown on soil treated with an excess of calcium and phosphorus fertilizer.
  • Functional analysis of the stratum corneum of scalp skin: studies in patients with alopecia areata and androgenetic alopecia.
  • Contraceptive methods for adolescents
  • Oral etoposide therapy in stage III-IV ovarian carcinoma
  • Surgical treatment strategies for baldness
  • Phase II collaborative study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) for urological malignancies--Urological Co-operative THP Study Group
  • A cooperative phase II study of vindesine sulfate in patients with solid tumors
  • A phase I pharmacokinetic study of 21-day continuous infusion mitoxantrone.
  • Blood lymphocyte subpopulations and antibody dependent, cell-mediated cytotoxicity (ADCC) in alopecia areata and universalis.
  • Effect of thyroid hormone supplementation on chronic doxorubicin (adriamycin)-induced cardiotoxicity and serum concentrations of T3 and T4 in dogs.
  • Aids to scalp reduction surgery.
  • Clinical aspects and surgical treatment of hyperadrenocorticism in the domestic ferret: 94 cases (1994-1996).
  • HLA-DQA1*0301-associated susceptibility for autoimmune polyglandular syndrome type II and III.
  • Alopecia areata in children
  • Cutaneous signs and symptoms of X-linked chondrodysplasia punctata in man and mouse
  • Incidence of female androgenetic alopecia (female pattern alopecia).
  • Natural history of androgenetic alopecia.
  • Evaluation of polyamide synthetic hair. A long-term clinical study.
  • Five new mutations in the Syrian hamster: furloss, fur-deficiency, juvenile gray, ashen, and quaking.
  • Treatment of cutaneous T-cell lymphomas (CTCL) with extracorporeal photochemotherapy--preliminary report.
  • The hairless gene in androgenetic alopecia: results of a systematic mutation screening and a family-based association approach.
  • Evaluation of the teratogenic potential of a spray adhesive in hamsters.
  • EEG findings, rapid ACTH test and autonomic nervous symptoms in patients with alopecia areata.
  • When your patients lose their hair.
  • Intensive chemotherapy for adult acute lymphoblastic leukaemia given with or without granulocyte-macrophage colony stimulating factor.
  • Ultrastructural abnormalities in the dermal papillae of both lesional and clinically normal follicles from alopecia areata scalps.
  • Influence of estrogens on the androgen metabolism in different subunits of human hair follicles.
  • Familial hypotrichosis of the scalp. Autosomal dominant inheritance in four generations.
  • T cell subpopulations and their functions in vitro. A study in patients with alopecia areata and alopecia universalis.
  • Improvement in the therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus fludarabine.
  • Is baldness a thermoregulatory adaptive process?
  • Two different mutations in the same codon of a type II hair keratin (hHb6) in patients with monilethrix.
  • Nasal reconstruction using the Washio retroauricular temporal flap.
  • THP-adriamycin: status of the clinical development of a new anthracycline in France
  • Prevalence of nail abnormalities in children with alopecia areata.
  • Dermatological findings in children exposed transplacentally to heat-degraded polychlorinated biphenyls in Taiwan.
  • Role of scalp reduction in the treatment of male pattern baldness.
  • Semiquantitative study of tinea capitis and the asymptomatic carrier state in inner-city school children.
  • Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice.
  • Genetic factors predispose to balding and non-balding in men.
  • Safety and efficacy of 2% topical minoxidil in the management of male pattern baldness in Chinese.
  • Treatment of alopecia totalis with a combination of inosine pranobex and diphencyprone compared to each treatment alone.
  • Novel Hairless mutations in two kindreds with autosomal recessive papular atrichia.
  • Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects.
  • Corrective hair restoration techniques for the aesthetic problems of temperoparietal flaps.
  • Treatment of hirsutism with the pure antiandrogen flutamide.
  • Cutaneous complications of chemotherapeutic agents.
  • Complications of controlled tissue expansion in the pediatric burn patient.
  • Surgical procedures for the treatment of baldness.
  • Innovative adjuncts in hair transplantation.
  • Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung.
  • Laser hair transplantation. Tissue effects of laser parameters.
  • Immunohistological study of the development of the cellular infiltrate in the pelage follicles of the DEBR model for alopecia areata.
  • Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least 1 year.
  • Eosinophils in fibrous tracts and near hair bulbs: a helpful diagnostic feature of alopecia areata.
  • Mini-slit graft hair transplantation using the Ultrapulse carbon dioxide laser handpiece.
  • Ornithine decarboxylase transgenic mice as a model for human atrichia with papular lesions.
  • Problems in evaluating chronic toxicity of contraceptive steroids in dogs.
  • Use of lufenuron for treating fungal infections of dogs and cats: 297 cases (1997-1999).
  • Mitoxantrone in the treatment of relapsed and refractory acute leukemia.
  • Tolerance to long-term treatment of malignant midgut carcinoid with a highly purified human leukocyte alpha-interferon.
  • Sodium valproate in the treatment of resistant epilepsy.
  • Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone.
  • 1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia.
  • Liposomal doxorubicin for treatment of AIDS-related Kaposi's sarcoma.
  • Traumatic alopecia in trichotillomania: a pathogenic interpretation of histologic lesions in the pilosebaceous unit.
  • Hypnotherapy: an effective treatment modality for trichotillomania.
  • Experience with laser hair transplantation in Orientals.
  • Oral etoposide preceding cisplatin in advanced non small cell lung cancer (NSCLC). A phase II study.
  • Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
  • Immunohistologic and ultrastructural comparison of the dermal papilla and hair follicle bulb from "active" and "normal" areas of alopecia areata.
  • Retinoid-selective ultraviolet phototherapy (SUP) in psoriasis
  • Alopecia areata and universalis in the Smyth chicken model for spontaneous autoimmune vitiligo.
  • Gemcitabine: safety profile unaffected by starting dose.
  • Outcomes of adolescents using levonorgestrel implants vs oral contraceptives or other contraceptive methods.
  • Neoadjuvant chemotherapy using cisplatin (CDDP) and methotrexate (MTX) in carcinoma of the bladder
  • Behcet's disease: uveitis-therapy with interferon alpha2a - prospective clinical study in 33 patients
  • Adriamycin, bleomycin, vinblastine and imidazole carboxamide (ABVD) therapy for advanced Hodgkin's disease resistant to mustine, vinblastine, procarbazine and prednisolone (MVPP).
  • Mitoxantrone combined to vincristine, cyclophosphamide and fluorouracil in advanced breast cancer.
  • research_abst
  • Antioxidant function of vitamin A.
  • A genetic, pathological and virological study of congenital hypotrichosis and incisor anodontia in cattle.
  • Treatment of psoriasis vulgaris with a new retinoic acid derivative Ro 10-9359; An uncontrolled clinical trial.
  • Skin expansion. A new weapon in the therapeutic arsenal of plastic surgeons
  • Restoration of hair growth with topical diphencyprone in mouse and rat models of alopecia areata.
  • Treatment of burn alopecia with tissue expanders in children.
  • Trachyonychia associated with alopecia areata: a clinical and pathologic study.
  • T cell repertoire in mice with alopecia areata.
  • Alopecia in mice infected with murine cytomegalovirus (MCMV).
  • Hair transplantation in women: treating female pattern baldness and repairing distortion and scarring from prior cosmetic surgery.
  • 2-Chlorodeoxyadenosine (Cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger.
  • The lateral scalp flap for anterior hairline reconstruction.
  • Sebaceous adenitis in dogs and results of treatment with isotretinoin and etretinate: 30 cases (1990-1994).
  • Hair loss during treatment with oral contraceptives
  • Therapy of alopecia areata with diphenylcyclopropenone
  • Gray hair, baldness, and wrinkles in relation to myocardial infarction: the Copenhagen City Heart Study.
  • Clinical use of antiandrogens in the female
  • Human leukocyte antigen-DQB1*03 alleles are associated with alopecia areata.
  • Host priming, not target antigen type, decides rejection rate in mice primed with MHC II "knockout" cultured keratinocytes.
  • Weak direct current accelerates split-thickness graft healing on tangentially excised second-degree burns.
  • A new murine model of accelerated senescence.
  • Reappraisal of Ikeda's classification of alopecia areata: analysis of 356 cases from Chandigarh, India.
  • An analysis of various aspects of atomic bomb dose estimation at RERF using data on acute radiation symptoms.
  • Early onset of androgenetic alopecia associated with early severe coronary heart disease: a population-based, case-control study.
  • Laboratory diagnosis of the atopic condition: evaluation of a possible method based on human serum complement consumption.
  • Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
  • Decreased serum ferritin is associated with alopecia in women.
  • Micrografts and minigrafts: a new approach for baldness surgery.
  • Induction of hair growth in alopecia totalis with diphencyprone sensitization.
  • The effect of cyproterone acetate on hair roots and hair shaft diameter in androgenetic alopecia in females.
  • Corroborative evidence that alopecia areata involves the epidermis and the sebaceous glands.
  • Massive lymphocyte-mediated apoptosis during the early stage of pseudopelade.
  • Suppressor cell decrease in alopecia areata.
  • Lichen planopilaris: clinical and pathologic study of forty-five patients.
  • High-dose cyclophosphamide. An effective treatment for advanced refractory multiple myeloma.
  • Dermatological non-disease: a common and potentially fatal disturbance of cutaneous body image.
  • PUVA treatment for alopecia areata.
  • Hyperplasia, hyperkeratosis and benign tumor production in transgenic mice by a targeted v-fos oncogene suggest a role for fos in epidermal differentiation and neoplasia.
  • PUVA treatment for alopecia areata--does it work? A retrospective review of 102 cases.
  • Stress and alopecia areata: a psychodermatologic study.
  • Doxorubicin chemotherapy in advanced transitional cell carcinoma.
  • Congenital atrichia in five Arab Palestinian families resulting from a deletion mutation in the human hairless gene.
  • Anticancer drugs induce apoptosis in mouse hair follicles.
  • Alopecia: a systematic appraoch to diagnosis and therapy.
  • Parietal cephalocele: clinical importance of its atretic form and associated malformations.
  • High-dose cytosine arabinoside: response to therapy in acute leukaemia and non-Hodgkin's lymphoma.
  • Life events and alopecia areata.
  • Treatment of hirsutism and acne in women with two combinations of cyproterone acetate and ethinylestradiol.
  • Alopecia areata
  • Mitoxantrone in refractory acute leukemia in children: a phase I study.
  • Side effects due to RO 10-9359 (Tigason). A retrospective study.
  • An effective low-dose adriamycin regimen as secondary chemotherapy for metastatic breast cancer patients.
  • Effects of interleukins, colony-stimulating factor and tumour necrosis factor on human hair follicle growth in vitro: a possible role for interleukin-1 and tumour necrosis factor-alpha in alopecia areata.
  • Chemotherapeutic combinations of mutually potentiating drugs. 2-Application to the treatment of bronchial cancers
  • Steroidogenic response of adrenal tissues after administration of ACTH to dogs with hypercortisolemia.
  • Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer.
  • Evidence for a complement-mediated inhibition and an antibody-dependent cellular cytotoxicity of dermal fibroblasts in alopecia areata.
  • Dermatological complications in immunosuppressed patients after kidney transplantation
  • Telomerase activity concentrates in the mitotically active segments of human hair follicles.
  • Alopecia in calves associated with milk substitute feeding.
  • High-dose ifosfamide in advanced osteosarcoma.
  • Ethynodiol diacetate as a contraceptive.
  • Adriamycin therapy by continuous intravenous infusion in patients with metastatic breast cancer.
  • Alopecia from oral contraceptives.
  • Expression of desmoglein 1 compensates for genetic loss of desmoglein 3 in keratinocyte adhesion.
  • Midline alopecia reduction combined with hair transplantation.
  • Tissue expansion in the correction of burn alopecia: classification and methods of correction.
  • Pulsed administration of corticosteroids in the treatment of alopecia areata.
  • Some concerns and semantic confusions about feminine skin
  • Acanthosis nigricans: a new cutaneous sign in severe atopic dermatitis and Down syndrome.
  • Diseases sometimes associated with psoriasis. II. Alopecia areata.
  • An early phase II study of CPT-11 in primary lung cancer
  • Toxicity of cisplatin with continuous infusion of 5-fluorouracil in neoadjuvant chemotherapy of carcinoma of the oral cavity
  • Growing old gracefully: age concealment and gender.
  • Forum on tissue expansion. Conclusion. How to master expansion...
  • Cutaneous manifestations of childhood systemic lupus erythematosus.
  • Chronic cutaneous damage after accidental exposure to ionizing radiation: the Chernobyl experience.
  • Control of Psoroptes cuniculi in captive white-tailed deer with ivermectin-treated corn.
  • Interleukin 1 protects against 1-beta-D-arabinofuranosylcytosine-induced alopecia in the newborn rat animal model.
  • The sequelae of chronic cutaneous lupus erythematosus.
  • Drug eruption induced by cyanamide (carbimide): a clinical and histopathologic study of 7 patients.
  • Serum androgens: associations with prostate cancer risk and hair patterning.
  • Adriamycin, cyclophosphamide, ftorafur and tamoxifen (ACFT) in patients with advanced breast cancer
  • A combination of cyclophosphamide, methotrexate, vincristine and VP 16-213 (NSC 141 540) in the treatment of bronchogenic carcinoma.
  • Malignant neoplasms in cyclosporin A-induced autoimmunity (CyA-AI).
  • Vindesine: an effective agent in the treatment of non-small cell lung cancer.
  • High-dose proinflammatory cytokines induce apoptosis of hair bulb keratinocytes in vivo.
  • Chronic iodine toxicity in dairy cattle: blood chemistry, leukocytes, and milk iodide.
  • Partial biotinidase deficiency: clinical and biochemical features.
  • Protein synthesis in zinc deficient rats during tularemia.
  • Follicular liposomal delivery systems.
  • Ataxia, depression, and dermatitis associated with the use of dichlorvos-impregnated collars in the laboratory cat.
  • Alopecia universalis associated with a mutation in the human hairless gene.











    Herbs and Pharmaceuticals Online || Hair Million herbal formula for hair loss and hair growth || Hair loss research references || E-Mail Us